QA: Orgenesis Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2023_Orgenesis_Inc.pdf

Logs

Graph

Absolute values for 0001460602, Orgenesis Inc.

  xvar xval
0 AssetsCurrent 46,318,000
1 IntangibleAssetsNetIncludingGoodwill 17,881,000
2 PropertyPlantAndEquipmentNet 22,834,000
3 remainder_Assets 3,895,000
4 LiabilitiesCurrent 15,910,000
5 LiabilitiesNoncurrent 15,744,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 27,066,000
8 SellingGeneralAndAdministrativeExpense 15,589,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,181,000
11 remainder_Revenues 36,025,000
12 remainder_NetIncome -3,358,000
13 remainder_ComprehensiveNetIncome -2,243,000
  yvar yval
0 Assets 90,928,000
1 Liabilities 31,654,000
2 Expenses 44,836,000
3 Revenues 36,025,000
4 StockholdersEquity 59,274,000
5 NetIncome -12,169,000
6 ComprehensiveNetIncome -13,290,500
7 BaseVar 104,522,000
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time